Yüklüyor......
ELISA reagent coverage evaluation by affinity purification tandem mass spectrometry
Host cell proteins (HCPs) must be adequately removed from recombinant therapeutics by downstream processing to ensure patient safety, product quality, and regulatory compliance. HCP process clearance is typically monitored by enzyme-linked immunosorbent assay (ELISA) using a polyclonal reagent. Rece...
Kaydedildi:
| Yayımlandı: | MAbs |
|---|---|
| Asıl Yazarlar: | , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Taylor & Francis
2017
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5627587/ https://ncbi.nlm.nih.gov/pubmed/28708446 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/19420862.2017.1349586 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|